Skip Navigation


Annals of Oncology Advance Access originally published online on June 9, 2006
Annals of Oncology 2006 17(7):1037-1038; doi:10.1093/annonc/mdl123
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
17/7/1037    most recent
mdl123v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bottomley, A.
Right arrow Articles by Efficace, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bottomley, A.
Right arrow Articles by Efficace, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 European Society for Medical Oncology

editorial

Predicting survival in advanced cancer patients: is it possible with patient-reported health status data?

A. Bottomley* and F. Efficace

Quality of Life Unit, European Organisation for Research and Treatment of Cancer, AISBL-IVZW, Brussels, Belgium

* (E-mail: abo@eortc.be)

The first 10% of the full text of this article appears below.

How long will I live? That is one of the most fundamental questions humans have sought to answer over the ages. This question becomes far more important when patients develop a life threatening illness, such as cancer. Fundamentally, being able to predict how long the patient will survive can be essential in clinical decision making. Determining this key-issue assists clinicians to identify patients who will benefit from treatment; further, it could help avoid over-treatment of patients who will gain no benefit from, often, toxic and aggressive therapies.

There is now huge body of research being conducted to evaluate methods of prognostic analysis. In any mainstream oncology journal, it is increasingly difficult not to read an . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?